首頁 > 市場調查報告書 > 醫療設備

整形外科

市場調查報告書

商品編碼

1547703

全球黏稠補充劑市場研究報告 - 2024 年至 2032 年行業分析、規模、佔有率、成長、趨勢和預測

Global Viscosupplementation Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2024 to 2032

出版日期: 2024年07月01日 | 出版商:

Value Market Research | 英文 128 Pages | 商品交期: 最快1-2個工作天內

價格

簡介目錄圖表

全球黏稠補充劑市場需求預計將從 2023 年的 53.2 億美元達到近 125.5 億美元的市場規模，2024-2032 年研究期間複合年成長率為 10.01%。

黏性補充是骨關節炎的一種治療方法。這裡將一種稱為透明質酸的凝膠狀液體注入膝關節，起到潤滑劑的作用。這種注射有利於膝關節的平滑運動，並減少膝蓋周圍的腫脹或疼痛。透明質酸可作為關節負荷的減震器並改善膝蓋功能。補充黏液不會逆轉關節炎的過程或使軟骨重新生長，如果關節炎處於早期階段，則非常有效。這種治療方法適用於試圖延遲關節手術的患者。它也可用於治療某些類風濕性關節炎。

市場動態

對於骨關節炎患者長期緩解疼痛和恢復活動能力的非手術治療的日益偏好將是有利於該市場成長的少數基本因素。生活方式引起的疾病的出現以及所有收入群體對適當治療和治癒的需求顯著增加將進一步推動市場成長。對醫療保健行業的高投資使人們能夠輕鬆獲得可用的診斷和治療方案，這將促進市場成長。專業骨科診所和門診手術中心數量的增加將成為市場的助推器。缺乏黏稠補充劑有效性和安全性的臨床證據繼續阻礙該市場的成長。

研究報告涵蓋波特五力模型、市場吸引力分析和價值鏈分析。這些工具有助於清晰地了解行業結構並評估全球範圍內的競爭吸引力。此外，這些工具還對全球黏稠補充劑市場的每個細分市場進行了包容性評估。黏稠補充劑產業的成長和趨勢為本研究提供了整體方法。

市場區隔

黏稠補充劑市場報告的這一部分提供了有關國家和區域級別細分市場的詳細資料，從而幫助策略師確定相應產品或服務的目標人口統計數據以及即將到來的機會。

按產品分類

單次注射
三注射
五注射

按最終用途

醫院
骨科診所/ASC

區域分析

本節涵蓋區域前景，重點介紹北美、歐洲、亞太地區、拉丁美洲以及中東和非洲粘膠補充劑市場當前和未來的需求。此外，該報告重點關注所有主要地區各個應用領域的需求、估計和預測。

該研究報告還涵蓋了市場主要參與者的全面概況以及對全球競爭格局的深入了解。黏稠補充劑市場的主要參與者包括DePuy Synthes、Fidia Farmaceutici SPA、賽諾菲、Smith & Nephew PLC、Anika Therapeutics Inc.、Seikagaku Corp.、Zimmer Biomet、Ferring Pharmaceuticals BV、Lifecore Biomedical、LG Life Sciences Ltd. 、F.Hoffmann -拉羅氏有限公司。發展。

如果您有任何客製化要求，請寫信給我們。我們的研究團隊可以根據您的需求提供客製化報告。

區域展望
介紹
北美銷售分析
- 概覽、歷史與預測資料銷售分析
- 北美按細分市場銷售分析
- 北美按國家銷售分析
- 美國銷售分析
- 加拿大銷售分析
- 墨西哥銷售分析
歐洲銷售分析
- 概覽、歷史與預測資料銷售分析
- 歐洲按細分市場銷售分析
- 歐洲按國家銷售分析
- 英國銷售分析
- 法國銷售分析
- 德國銷售分析
- 義大利銷售分析
- 俄羅斯銷售分析
- 歐洲其他地區銷售分析
亞太地區銷售分析
- 概覽、歷史與預測資料銷售分析
- 亞太地區按細分市場銷售分析
- 亞太地區按國家銷售分析
- 中國銷售分析
- 印度銷售分析
- 日本銷售分析
- 韓國銷售分析
- 澳洲銷售分析
- 東南亞銷售分析
- 亞太地區其他地區銷售分析
拉丁美洲銷售分析
- 概覽、歷史與預測資料銷售分析
- 拉丁美洲按細分市場銷售分析
- 拉丁美洲按國家銷售分析
- 巴西銷售分析
- 阿根廷銷售分析
- 秘魯銷售分析
- 智利銷售分析
- 拉丁美洲其他地區銷售分析
中東和非洲銷售分析
- 概覽、歷史與預測資料銷售分析
- 中東和非洲按細分市場銷售分析
- 中東和非洲按國家銷售分析
- 沙烏地阿拉伯銷售分析
- 阿拉伯聯合大公國銷售分析
- 以色列銷售分析
- 南非銷售分析
- 中東其他地區和非洲銷售分析

第 8 章：黏稠補充劑公司的競爭格局

黏稠補充劑市場競爭
夥伴關係/協作/協議
併購
新產品發布
其他發展

第 9 章：公司簡介

頂級公司市佔率分析
市場集中度
DePuy Synthes

公司概況
公司收入
產品
最新動態

Fidia Farmaceutici SPA

公司概況
公司收入
產品
最新動態

Sanofi

公司概況
公司收入
產品
最新動態

Smith & Nephew PLC

公司概況
公司收入
產品
最新動態

Anika Therapeutics Inc.

公司概況
公司收入
產品
最新動態

Seikagaku Corp.

公司概況
公司收入
產品
最新動態

Zimmer Biomet

公司概況
公司收入
產品
最新動態

Ferring Pharmaceuticals BV

公司概況
公司收入
產品
最新動態

Lifecore Biomedical

公司概況
公司收入
產品
最新動態

LG Life Sciences Ltd.

公司概況
公司收入
產品
最新動態

F.Hoffmann-La Roche Ltd

公司概況
公司收入
產品
最新動態

註 - 在公司概況中，財務詳細資訊和最新發展視情況而定，或對私人公司而言可能不包括在內

簡介目錄圖表

Product Code: VMR11213813

The global demand for Viscosupplementation Market is presumed to reach the market size of nearly USD 12.55 Billion by 2032 from USD 5.32 Billion in 2023 with a CAGR of 10.01% under the study period 2024-2032.

Viscosupplementation is a treatment procedure for osteoarthritis. Here a gel-like fluid called hyaluronic acid injected into the knee joint acts as a lubricant. This injection facilitates smooth movement of knee joints and reduces swelling or pain around the knee. Hyaluronic acid acts as a shock absorber for loads at the joint and improves knee function. Viscosupplementation does not reverse the arthritic process or re-grow cartilages and is highly effective if the arthritis is in its early stages. This treatment is considered for patients trying to delay getting surgery on the joint. It can be used to treat some instances of rheumatoid arthritis as well.

MARKET DYNAMICS

The increased preference for nonsurgical procedures for long-lasting pain relief and mobility restoration in osteoarthritis patients will be the few essential elements favoring this market's growth. The emergence of lifestyle-induced disorders and a significant rise in the demand for proper treatment and cure among people of all income groups will further propel market growth. High investments in the healthcare industry to enable easy access to available diagnosis and treatment options will boost the market growth. A rise in the number of specialized orthopedic clinics and ambulatory surgical centers will be a market booster. The lack of clinical evidence on viscosupplementation's effectiveness and safety continues to hamper this market's growth.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of Viscosupplementation. The growth and trends of Viscosupplementation industry provide a holistic approach to this study.

MARKET SEGMENTATION

This section of the Viscosupplementation market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Product

Single Injection
Three Injection
Five Injection

By End-use

Hospitals
Orthopedic Clinics/ASCs

REGIONAL ANALYSIS

This section covers the regional outlook, which accentuates current and future demand for the Viscosupplementation market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Viscosupplementation market include DePuy Synthes, Fidia Farmaceutici S.P.A, Sanofi, Smith & Nephew PLC, Anika Therapeutics Inc., Seikagaku Corp., Zimmer Biomet, Ferring Pharmaceuticals B.V., Lifecore Biomedical, LG Life Sciences Ltd., F.Hoffmann-La Roche Ltd. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

1. PREFACE

1.1. Report Description
- 1.1.1 Objective
- 1.1.2 Target Audience
- 1.1.3 Unique Selling Proposition (USP) & offerings
1.2. Research Scope
1.3. Research Methodology
- 1.3.1 Market Research Process
- 1.3.2 Market Research Methodology

2. EXECUTIVE SUMMARY

2.1. Highlights of Market
2.2. Global Market Snapshot

3. VISCOSUPPLEMENTATION - INDUSTRY ANALYSIS

3.1. Introduction - Market Dynamics
3.2. Market Drivers
3.3. Market Restraints
3.4. Opportunities
3.5. Industry Trends
3.6. Porter's Five Force Analysis
3.7. Market Attractiveness Analysis
- 3.7.1 Market Attractiveness Analysis By Product
- 3.7.2 Market Attractiveness Analysis By End-use
- 3.7.3 Market Attractiveness Analysis By Region

4. VALUE CHAIN ANALYSIS

4.1. Value Chain Analysis
4.2. Raw Material Analysis
- 4.2.1 List of Raw Materials
- 4.2.2 Raw Material Manufactures List
- 4.2.3 Price Trend of Key Raw Materials
4.3. List of Potential Buyers
4.4. Marketing Channel
- 4.4.1 Direct Marketing
- 4.4.2 Indirect Marketing
- 4.4.3 Marketing Channel Development Trend

5. GLOBAL VISCOSUPPLEMENTATION MARKET ANALYSIS BY PRODUCT

5.1. Overview By Product
5.2. Historical and Forecast Data
5.3. Analysis By Product
5.4. Single Injection Historic and Forecast Sales By Regions
5.5. Three Injection Historic and Forecast Sales By Regions
5.6. Five Injection Historic and Forecast Sales By Regions

6. GLOBAL VISCOSUPPLEMENTATION MARKET ANALYSIS BY END-USE

6.1. Overview By End-use
6.2. Historical and Forecast Data
6.3. Analysis By End-use
6.4. Hospitals Historic and Forecast Sales By Regions
6.5. Orthopedic Clinics/ASCs Historic and Forecast Sales By Regions

7. GLOBAL VISCOSUPPLEMENTATION MARKET ANALYSIS BY GEOGRAPHY

7.1. Regional Outlook
7.2. Introduction
7.3. North America Sales Analysis
- 7.3.1 Overview, Historic and Forecast Data Sales Analysis
- 7.3.2 North America By Segment Sales Analysis
- 7.3.3 North America By Country Sales Analysis
- 7.3.4 United States Sales Analysis
- 7.3.5 Canada Sales Analysis
- 7.3.6 Mexico Sales Analysis
7.4. Europe Sales Analysis
- 7.4.1 Overview, Historic and Forecast Data Sales Analysis
- 7.4.2 Europe By Segment Sales Analysis
- 7.4.3 Europe By Country Sales Analysis
- 7.4.4 United Kingdom Sales Analysis
- 7.4.5 France Sales Analysis
- 7.4.6 Germany Sales Analysis
- 7.4.7 Italy Sales Analysis
- 7.4.8 Russia Sales Analysis
- 7.4.9 Rest Of Europe Sales Analysis
7.5. Asia Pacific Sales Analysis
- 7.5.1 Overview, Historic and Forecast Data Sales Analysis
- 7.5.2 Asia Pacific By Segment Sales Analysis
- 7.5.3 Asia Pacific By Country Sales Analysis
- 7.5.4 China Sales Analysis
- 7.5.5 India Sales Analysis
- 7.5.6 Japan Sales Analysis
- 7.5.7 South Korea Sales Analysis
- 7.5.8 Australia Sales Analysis
- 7.5.9 South East Asia Sales Analysis
- 7.5.10 Rest Of Asia Pacific Sales Analysis
7.6. Latin America Sales Analysis
- 7.6.1 Overview, Historic and Forecast Data Sales Analysis
- 7.6.2 Latin America By Segment Sales Analysis
- 7.6.3 Latin America By Country Sales Analysis
- 7.6.4 Brazil Sales Analysis
- 7.6.5 Argentina Sales Analysis
- 7.6.6 Peru Sales Analysis
- 7.6.7 Chile Sales Analysis
- 7.6.8 Rest of Latin America Sales Analysis
7.7. Middle East & Africa Sales Analysis
- 7.7.1 Overview, Historic and Forecast Data Sales Analysis
- 7.7.2 Middle East & Africa By Segment Sales Analysis
- 7.7.3 Middle East & Africa By Country Sales Analysis
- 7.7.4 Saudi Arabia Sales Analysis
- 7.7.5 UAE Sales Analysis
- 7.7.6 Israel Sales Analysis
- 7.7.7 South Africa Sales Analysis
- 7.7.8 Rest Of Middle East And Africa Sales Analysis

8. COMPETITIVE LANDSCAPE OF THE VISCOSUPPLEMENTATION COMPANIES

8.1. Viscosupplementation Market Competition
8.2. Partnership/Collaboration/Agreement
8.3. Merger And Acquisitions
8.4. New Product Launch
8.5. Other Developments

9. COMPANY PROFILES OF VISCOSUPPLEMENTATION INDUSTRY

9.1. Top Companies Market Share Analysis
9.2. Market Concentration Rate
9.3. DePuy Synthes
- 9.3.1 Company Overview
- 9.3.2 Company Revenue
- 9.3.3 Products
- 9.3.4 Recent Developments
9.4. Fidia Farmaceutici S.P.A
- 9.4.1 Company Overview
- 9.4.2 Company Revenue
- 9.4.3 Products
- 9.4.4 Recent Developments
9.5. Sanofi
- 9.5.1 Company Overview
- 9.5.2 Company Revenue
- 9.5.3 Products
- 9.5.4 Recent Developments
9.6. Smith & Nephew PLC
- 9.6.1 Company Overview
- 9.6.2 Company Revenue
- 9.6.3 Products
- 9.6.4 Recent Developments
9.7. Anika Therapeutics Inc.
- 9.7.1 Company Overview
- 9.7.2 Company Revenue
- 9.7.3 Products
- 9.7.4 Recent Developments
9.8. Seikagaku Corp.
- 9.8.1 Company Overview
- 9.8.2 Company Revenue
- 9.8.3 Products
- 9.8.4 Recent Developments
9.9. Zimmer Biomet
- 9.9.1 Company Overview
- 9.9.2 Company Revenue
- 9.9.3 Products
- 9.9.4 Recent Developments
9.10. Ferring Pharmaceuticals B.V.
- 9.10.1 Company Overview
- 9.10.2 Company Revenue
- 9.10.3 Products
- 9.10.4 Recent Developments
9.11. Lifecore Biomedical
- 9.11.1 Company Overview
- 9.11.2 Company Revenue
- 9.11.3 Products
- 9.11.4 Recent Developments
9.12. LG Life Sciences Ltd.
- 9.12.1 Company Overview
- 9.12.2 Company Revenue
- 9.12.3 Products
- 9.12.4 Recent Developments
9.13. F.Hoffmann-La Roche Ltd
- 9.13.1 Company Overview
- 9.13.2 Company Revenue
- 9.13.3 Products
- 9.13.4 Recent Developments